![Andreas Moraitis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas Moraitis
Directeur Technique/Scientifique/R&D chez
MBX BIOSCIENCES, INC.
Profil
Dr. Andreas Moraitis, MD, is a Senior Vice President-Clinical Development at MBX Biosciences, Inc. Dr. Moraitis was previously employed as a Head-Clinical Development by Corcept Therapeutics, Inc. He received his doctorate degree from National & Kapodistrian University of Athens.
Postes actifs de Andreas Moraitis
| Sociétés | Poste | Début |
|---|---|---|
| MBX BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 23/06/2025 |
Anciens postes connus de Andreas Moraitis
| Sociétés | Poste | Fin |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Corporate Officer/Principal | - |
Formation de Andreas Moraitis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Corcept Therapeutics, Inc.
 Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
National & Kapodistrian University of Athens
 National & Kapodistrian University of Athens Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
